Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy

Daniel E. Hilleman; E. C. Wadibia; B. Shinn

Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy

Daniel E. Hilleman, E. C. Wadibia, B. Shinn

Department of Pharmacy Practice

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV,

Original language	English (US)
Pages (from-to)	36S
Journal	Chest
Volume	110
Issue number	4 SUPPL.
State	Published - Oct 1 1996

All Science Journal Classification (ASJC) codes

Pulmonary and Respiratory Medicine
Critical Care and Intensive Care Medicine
Cardiology and Cardiovascular Medicine

Cite this

@article{0725d5c06ca44983a58747895b0281d7,

title = "Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy",

abstract = "Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV, ",

author = "Hilleman, {Daniel E.} and Wadibia, {E. C.} and B. Shinn",

year = "1996",

month = oct,

day = "1",

language = "English (US)",

volume = "110",

pages = "36S",

journal = "Diseases of the chest",

issn = "0012-3692",

publisher = "American College of Chest Physicians",

number = "4 SUPPL.",

}

TY - JOUR

T1 - Pharmacoeconomic evaluation of COPD

T2 - Stratification of outcomes and costs according to initial drug therapy

AU - Hilleman, Daniel E.

AU - Wadibia, E. C.

AU - Shinn, B.

PY - 1996/10/1

Y1 - 1996/10/1

N2 - Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV,

AB - Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV,

UR - http://www.scopus.com/inward/record.url?scp=33746398668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746398668&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33746398668

VL - 110

SP - 36S

JO - Diseases of the chest

JF - Diseases of the chest

SN - 0012-3692

IS - 4 SUPPL.

ER -

Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this